Eyenovia to present at upcoming h.c. wainwright 25th annual global investment conference

New york, sept. 07, 2023 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), a commercial-stage ophthalmic technology company commercializing mydcombi™ (tropicamide+phenylephrine ophthalmic spray for mydriasis) and developing the optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced management will deliver a presentation at the h.c. wainwright 25th annual global investment conference, which is taking place on september 11-13, 2023 at the lotte new york palace hotel.
EYEN Ratings Summary
EYEN Quant Ranking